Anna Eshoo: “The time has come for action. We have already lost too many mothers to this crisis.”

I have to say that I am really deeply disappointed. Deeply disappointed.

The Medicaid Value-Based Payments for Patients Act will codify a CMS rule to help ensure Medicaid enrollees have access to breakthrough gene therapies.

I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's.

We need to get a clear explanation from hospitals on why, after hospitals acquire physician practices, the prices for the services provided by the acquired physicians increases by 14 percent.